2. Datta NR, Stutz E, Liu M, Rogers S, Klingbiel D, Siebenhüner A, et al. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: a systematic review and meta-analysis. Gynecol Oncol. 2017; 145(2):374–385.
https://doi.org/10.1016/j.ygyno.2017.01.033.
Article
3. Wang Y, Deng W, Li N, Neri S, Sharma A, Jiang W, et al. Combining immunotherapy and radiotherapy for cancer treatment: current challenges and future directions. Front Pharmacol. 2018; 9:185.
https://doi.org/10.3389/fphar.2018.00185.
Article
4. Alterio D, D'Ippolito E, Vischioni B, Fossati P, Gandini S, Bonora M, et al. Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy. Acta Oncol. 2020; 59(5):541–548.
https://doi.org/10.1080/0284186X.2020.1730001.
Article
5. Kim N, Noh JM, Lee W, Park B, Park H, Park JY, et al. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: a comparative analysis of proton versus photon therapy. Radiother Oncol. 2021; 156:166–173.
https://doi.org/10.1016/j.radonc.2020.12.019.
Article
7. Glaser SM, Mohindra P, Mahantshetty U, Beriwal S. Complications of intracavitary brachytherapy for gynecologic cancers and their management: a comprehensive review. Brachytherapy. 2021; 20(5):984–994.
https://doi.org/10.1016/j.brachy.2020.11.011.
Article
10. Viswanathan AN, Lee LJ, Eswara JR, Horowitz NS, Konstantinopoulos PA, Mirabeau-Beale KL, et al. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer. 2014; 120(24):3870–3883.
https://doi.org/10.1002/cncr.28849.
Article
11. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003; 13(3):176–181.
https://doi.org/10.1016/S1053-4296(03)00031-6.
Article
12. Yu C, Zhu W, Ji Y, Guo J, Pan P, Han J, et al. A comparative study of intensity-modulated radiotherapy and standard radiation field with concurrent chemotherapy for local advanced cervical cancer. Eur J Gynaecol Oncol. 2015; 36(3):278–282.
14. Linn YH, Thu KK, Win NH. Effect of probiotics for the prevention of acute radiation-induced diarrhoea among cervical cancer patients: a randomized double-blind placebo-controlled study. Probiotics Antimicrob Proteins. 2019; 11(2):638–647.
https://doi.org/10.1007/s12602-018-9408-9.
Article
15. Araujo IK, Muñoz-Guglielmetti D, Mollà M. Radiation-induced damage in the lower gastrointestinal tract: Clinical presentation, diagnostic tests and treatment options. Best Pract Res Clin Gastroenterol. 2020; 48-49:101707.
https://doi.org/10.1016/j.bpg.2020.101707.
Article
22. Small W Jr, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, et al. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys. 2007; 68(4):1081–1087.
https://doi.org/10.1016/j.ijrobp.2007.01.026.
Article